"Immunoglobulin Fragments" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Partial immunoglobulin molecules resulting from selective cleavage by proteolytic enzymes or generated through PROTEIN ENGINEERING techniques.
Descriptor ID |
D007128
|
MeSH Number(s) |
D12.644.541.500 D12.776.124.486.485.680 D12.776.124.790.651.680 D12.776.377.715.548.680
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Immunoglobulin Fragments".
Below are MeSH descriptors whose meaning is more specific than "Immunoglobulin Fragments".
This graph shows the total number of publications written about "Immunoglobulin Fragments" by people in this website by year, and whether "Immunoglobulin Fragments" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1999 | 1 | 0 | 1 |
2000 | 1 | 0 | 1 |
2002 | 0 | 1 | 1 |
2007 | 1 | 0 | 1 |
2010 | 1 | 0 | 1 |
2012 | 1 | 1 | 2 |
2017 | 1 | 0 | 1 |
2018 | 0 | 1 | 1 |
2021 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Immunoglobulin Fragments" by people in Profiles.
-
Human Antibody Domains and Fragments Targeting Neutrophil Elastase as Candidate Therapeutics for Cancer and Inflammation-Related Diseases. Int J Mol Sci. 2021 Oct 15; 22(20).
-
Kidney-targeted inhibition of protein kinase C-a ameliorates nephrotoxic nephritis with restoration of mitochondrial dysfunction. Kidney Int. 2018 08; 94(2):280-291.
-
Delayed hematologic toxicity following rattlesnake envenomation unresponsive to crotalidae polyvalent antivenom. Am J Emerg Med. 2017 Jul; 35(7):1038.e1-1038.e2.
-
Benefits of a 24-hour inhouse on-call program for pharmacy residents. Am J Health Syst Pharm. 2012 Dec 15; 69(24):2160-4.
-
Safety and cost-effectiveness of a clinical protocol implemented to standardize the use of Crotalidae polyvalent immune Fab antivenom at an academic medical center. Pharmacotherapy. 2012 May; 32(5):433-40.
-
Evidence-based, multidisciplinary approach to the development of a crotalidae polyvalent antivenin (CroFab) protocol at a university hospital. Ann Pharmacother. 2010 Mar; 44(3):447-55.
-
Antibody-mediated p53 protein therapy prevents liver metastasis in vivo. Cancer Res. 2007 Feb 15; 67(4):1769-74.
-
The antibody site in Atlantic salmon; phage display and modeling of scFv with anti-hapten binding ability. Dev Comp Immunol. 2002 Mar; 26(2):201-6.
-
Isolation of a high affinity scFv from a monoclonal antibody recognising the oncofoetal antigen 5T4. Biochim Biophys Acta. 2000 Dec 15; 1524(2-3):238-46.
-
Production and characterization of an anti-(MUC1 mucin) recombinant diabody. Cancer Immunol Immunother. 1999 Apr; 48(1):29-38.